The performance of a value set for the EQ-5D based on experienced health states in patients with inflammatory bowel disease

Value in Health

Volumn 15, Issue 1, 2012, Pages 151-157

  Leidl, Reiner ^a,b   Reitmeir, Peter ^a   Knig, Hans Helmut ^c   Stark, Rene ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Crohn's disease; decision utility; EQ 5D index; experience based valuation; ulcerative colitis

Indexed keywords

ACCURACY; ADULT; ANALYTICAL ERROR; ARTICLE; CONSTRUCT VALIDITY; CORRELATION ANALYSIS; CROHN DISEASE; DECISION MAKING; DISEASE ACTIVITY; ENTERITIS; EQ 5D QUESTIONNAIRE; FEMALE; GERMANY; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN ABSOLUTE ERROR; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; TEST RETEST RELIABILITY; ULCERATIVE COLITIS; UNITED KINGDOM; VISUAL ANALOG SCALE;

COLITIS, ULCERATIVE; CROHN DISEASE; GERMANY; HEALTH STATUS; HUMANS; MENTAL HEALTH; PAIN MEASUREMENT; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 84856018909     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2011.08.004     Document Type: Article

References (19)

1. A.O.M. Szende, N. Devlin EQ-5D Value Sets: Inventory, Comparative Review and User Guide 2007 Springer Dordrecht
2. G.W. Torrance, W. Furlong, D. Feeny Multi-attribute preference functions Health Utilities Index Pharmacoeconomics 7 1995 503 520
3. J. Brazier, J. Roberts, M. Deverill The estimation of a preference-based measure of health from the SF-36 J Health Econ 21 2002 271 292 (Pubitemid 34143147)
4. S. Knies, S.M. Evers, M.J. Candel Utilities of the EQ-5D: transferable or not? Pharmacoeconomics 27 2009 767 779
5. R. Leidl, P. Reitmeir A value set for the EQ-5D Based on experienced health states: development and testing for the German population Pharmacoeconomics 29 2011 521 534
6. F. Shanahan, C.N. Bernstein The evolving epidemiology of inflammatory bowel disease Curr Opin Gastroenterol 25 2009 301 305
7. C.A. Karwowski, D. Keljo, E. Szigethy Strategies to improve quality of life in adolescents with inflammatory bowel disease Inflamm Bowel Dis 15 2009 1755 1764
8. H.H. Konig, A. Ulshofer, M. Gregor Validation of the EuroQol questionnaire in patients with inflammatory bowel disease Eur J Gastroenterol Hepatol 14 2002 1205 1215 (Pubitemid 35476879)
9. R.G. Stark, P. Reitmeir, R. Leidl Validity, reliability, and responsiveness of the EQ-5D in inflammatory bowel disease in Germany Inflamm Bowel Dis 16 2010 42 51
10. W. Greiner, C. Claes, J.J. Busschbach Validating the EQ-5D with time trade off for the German population Eur J Health Econ 6 2005 124 130 (Pubitemid 40905009)
11. P. Dolan Modeling valuations for EuroQol health states Med Care 35 1997 1095 1108 (Pubitemid 127453463)
12. R. Stark, H.H. Konig, R. Leidl Costs of inflammatory bowel disease in Germany Pharmacoeconomics 24 2006 797 814 (Pubitemid 44232107)
13. W.R. Best, J. B, J.W. Singleton, F. Kern Jr Development of a Crohn's disease activity index National Cooperative Crohn's Disease Study Gastroenterology 70 1976 439 444
14. D. Rachmilewitz Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial BMJ 298 1989 82 86 (Pubitemid 19032930)
15. K.H. Janke, A. Raible, M. Bauer Questions on life satisfaction (FLZM) in inflammatory bowel disease Int J Colorectal Dis 19 2004 343 353 (Pubitemid 38868300)
16. M.P. Connolly, C.D. Poole, C.J. Currie Quality of life improvements attributed to combination therapy with oral and topical mesalazine in mild-to-moderately active ulcerative colitis Digestion 80 2009 241 246
17. J.M. Schulenburg Graf von der, C. Claes, W. Greiner The German version of the EuroQol questionnaire [in German] Zeitschrift fr Gesundheitswissenschaften/ J Public Health 6 1998 3 20
18. N.J. Devlin, A. Tsuchiya, K. Buckingham A uniform time trade off method for states better and worse than dead: feasibility study of the 'lead time' approach Health Econ 20 2011 348 361
19. S. Bernert, A. Fernandez, J.M. Haro Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries Value Health 12 2009 750 758